Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: JOHN W. who wrote (2493)	10/26/1997 2:47:00 PM
From: billkirn	of 6136

Just to support this PE thing. My sense is that AGPH's (at $50 per share) estimated PE of 27 for FY99 could be way off, maybe by a factor of 2. Also I think percent sales and earnings growth just might exceed microsoft's by an order of magnitude after FY99, and microsoft supports a PE of over 50. If AGPH were to maintain a PE of 50 to 60 and earnings were to meet somewhat higher and maybe more realistic expectations, I would expect the price to be closer to 200 than 50 by this time next year. Of course all sorts of things can happen, positive and negative. Bill

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next